JAK inhibitors in autoimmune ocular inflammatory diseases - A systematic review of case reports and series. [PDF]
Almerri S +3 more
europepmc +1 more source
Clinical applications of tacrolimus in the treatment of ocular diseases: a narrative literature review. [PDF]
Alghamdi AH.
europepmc +1 more source
Clinical characteristics and management of dupilumab-associated ocular surface disease in Japan. [PDF]
Shoji J, Ebihara N.
europepmc +1 more source
Tomographic and biomechanical refractive findings in ocular pediatric allergy. [PDF]
Tangpagasit W +2 more
europepmc +1 more source
Omalizumab for severe atopic keratoconjunctivitis. [PDF]
Taillé C, Doan S, Neukirch C, Aubier M.
europepmc +1 more source
Long-Term Safety and Efficacy of Tralokinumab in Patients with Moderate-to-Severe Atopic Dermatitis Treated for up to 6 Years: Final Results from the Open-Label Extension Trial ECZTEND. [PDF]
Blauvelt A +15 more
europepmc +1 more source
Predictive Factors of Suboptimal Response to Topical 0.1% Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: A Real-World Retrospective Study. [PDF]
Nassisi M +7 more
europepmc +1 more source
Sexual Dimorphism in Allergic and Mast Cell-Associated Diseases. [PDF]
Kotha A +8 more
europepmc +1 more source
The evidence-based indications of 0.1% topical tacrolimus in ophthalmology: a scoping review. [PDF]
Lam PD +5 more
europepmc +1 more source
Prevalence of allergic diseases and evaluation of total IgE and blood eosinophils as diagnostic biomarkers in Colombia, a tropical country. [PDF]
Sánchez J +4 more
europepmc +1 more source

